All Stories

  1. Impact of Nanosizing on Solubility and Dissolution Rate of Poorly Soluble Pharmaceuticals

    Article • Journal of Pharmaceutical Sciences, June 2015, Elsevier

    Dr Rutesh H Dave, Dr Sharad B Murdande

  2. Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?

    Article • Journal of Pharmaceutical Sciences, October 2011, Elsevier

    Dr Sharad B Murdande, Prof Robin H Bogner

  3. Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals

    Article • Pharmaceutical Research, September 2010, Springer Science + Business Media

    Dr Sharad B Murdande, Prof Robin H Bogner

  4. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

    Article • Journal of Pharmaceutical Sciences, March 2010, Elsevier

    Dr Sharad B Murdande, Prof Robin H Bogner